The socioeconomic gradient in all-cause mortality for women with breast cancer: findings from the 1998 to 2006 National Cancer Data Base with follow-up through 2011

Ann Epidemiol. 2015 Aug;25(8):549-55. doi: 10.1016/j.annepidem.2015.02.006. Epub 2015 Feb 19.

Abstract

Purpose: To analyze the association between socioeconomic status (SES) and all-cause mortality among women diagnosed with breast cancer before and after controlling for insurance status, race and ethnicity, stage, treatment modalities, and other demographic and hospital characteristics.

Methods: Data analyzed included follow-up through 2011 for 582,396 patients diagnosed between 1998 and 2006 with ductal carcinoma in situ or invasive (stage I-IV) breast cancer from the National Cancer Data Base. SES was measured by grouping patients into six income and education-level ZIP code categories. Hierarchical Cox regression models were used to analyze SES survival differences.

Results: Five- and 10-year survival probabilities for the highest SES group were 87.8% and 71.5%, versus 79.5% and 61.5% for the lowest SES group. Controlling for all covariates reduced the highest-to-lowest SES hazard ratio from 1.69 (95% confidence interval: 1.64-1.74) to 1.27 (95% confidence interval: 1.24-1.31). Results were virtually identical in models that included comorbidity and invasive cancer patients only.

Conclusions: Differences in insurance status, race, and stage at diagnosis are important components of SES disparities and explain about two-thirds of the initial SES survival disparity. The residual SES effect likely mirrors underlying social determinants of health for all American women.

Keywords: Breast cancer epidemiology; Lack of health insurance; Racial disparities; Socioeconomic status; Stage at diagnosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Age Factors
  • Aged
  • Aged, 80 and over
  • Antineoplastic Agents / therapeutic use
  • Breast Neoplasms / diagnosis
  • Breast Neoplasms / mortality*
  • Breast Neoplasms / therapy
  • Carcinoma, Intraductal, Noninfiltrating / diagnosis
  • Carcinoma, Intraductal, Noninfiltrating / mortality*
  • Female
  • Follow-Up Studies
  • Humans
  • Incidence
  • Insurance Coverage / statistics & numerical data*
  • Mastectomy
  • Middle Aged
  • Neoplasm Staging
  • Proportional Hazards Models
  • Registries
  • SEER Program
  • Social Class*
  • Socioeconomic Factors
  • Survival Rate
  • Survivors / statistics & numerical data*
  • United States / epidemiology
  • Young Adult

Substances

  • Antineoplastic Agents